B Barrou (Professeur des Universités, Praticien hospitalier) , M.-O Bitker (Professeur des Universités, praticien hospitalier) , A Grimaldi (Professeur des Universités, praticien hospitalier) , P Debré (Professeur des Universités, praticien hospitalier) , F Richard (Professeur des Universités, praticien hospitalier)
{"title":"胰腺移植:适应症、移植结果及前景","authors":"B Barrou (Professeur des Universités, Praticien hospitalier) , M.-O Bitker (Professeur des Universités, praticien hospitalier) , A Grimaldi (Professeur des Universités, praticien hospitalier) , P Debré (Professeur des Universités, praticien hospitalier) , F Richard (Professeur des Universités, praticien hospitalier)","doi":"10.1016/j.emcend.2003.10.002","DOIUrl":null,"url":null,"abstract":"<div><p>Pancreas transplantation is now a well established treatment for type I diabetes. More than 17 000 cases have been reported to the International Pancreas Transplant Registry. One year graft survival is around 80%. The majority of the cases are combined kidney and pancreas transplants harvested from the same donor in type I diabetics with an advanced nephropathy. However, the recent progresses in the field of immunosuppression have improved the results of isolated pancreas transplants or pancreas after kidney transplants. These 2 categories are not very frequent in Europe but could be more frequently offered in light of these results. Major breakthrough have also been done in the field of islets transplantation. A multicenter trial is currently in progress to assess whether the excellent results reported by a Canadian group are reproducible or not. If yes, this technique could have a place of choice for pancreatic endocrine function replacement.</p></div>","PeriodicalId":100422,"journal":{"name":"EMC - Endocrinologie","volume":"1 1","pages":"Pages 43-53"},"PeriodicalIF":0.0000,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcend.2003.10.002","citationCount":"0","resultStr":"{\"title\":\"Transplantation pancréatique : indications, résultats et perspectives\",\"authors\":\"B Barrou (Professeur des Universités, Praticien hospitalier) , M.-O Bitker (Professeur des Universités, praticien hospitalier) , A Grimaldi (Professeur des Universités, praticien hospitalier) , P Debré (Professeur des Universités, praticien hospitalier) , F Richard (Professeur des Universités, praticien hospitalier)\",\"doi\":\"10.1016/j.emcend.2003.10.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Pancreas transplantation is now a well established treatment for type I diabetes. More than 17 000 cases have been reported to the International Pancreas Transplant Registry. One year graft survival is around 80%. The majority of the cases are combined kidney and pancreas transplants harvested from the same donor in type I diabetics with an advanced nephropathy. However, the recent progresses in the field of immunosuppression have improved the results of isolated pancreas transplants or pancreas after kidney transplants. These 2 categories are not very frequent in Europe but could be more frequently offered in light of these results. Major breakthrough have also been done in the field of islets transplantation. A multicenter trial is currently in progress to assess whether the excellent results reported by a Canadian group are reproducible or not. If yes, this technique could have a place of choice for pancreatic endocrine function replacement.</p></div>\",\"PeriodicalId\":100422,\"journal\":{\"name\":\"EMC - Endocrinologie\",\"volume\":\"1 1\",\"pages\":\"Pages 43-53\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2004-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.emcend.2003.10.002\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EMC - Endocrinologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1762565303000042\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Endocrinologie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1762565303000042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Transplantation pancréatique : indications, résultats et perspectives
Pancreas transplantation is now a well established treatment for type I diabetes. More than 17 000 cases have been reported to the International Pancreas Transplant Registry. One year graft survival is around 80%. The majority of the cases are combined kidney and pancreas transplants harvested from the same donor in type I diabetics with an advanced nephropathy. However, the recent progresses in the field of immunosuppression have improved the results of isolated pancreas transplants or pancreas after kidney transplants. These 2 categories are not very frequent in Europe but could be more frequently offered in light of these results. Major breakthrough have also been done in the field of islets transplantation. A multicenter trial is currently in progress to assess whether the excellent results reported by a Canadian group are reproducible or not. If yes, this technique could have a place of choice for pancreatic endocrine function replacement.